Karin Schmitt is a Chief Operating Officer at Mursla Bio. She possess expertise in drug discovery, stem cells, lifesciences, functional genomics, genomics and 13 more skills. Colleagues describe her as "Karin is one of the highest quality R&D Executives I have worked with in my 25 years in the biotechnology industry. She has been an early employee in some bleeding edge biotech companies including Millennium, Exelixis and Horizon. She has great breadth of scientific knowledge, has deep insights into market needs, is deeply analytical and is outstanding at aligning teams to a common purpose. Karin operates at an executive level and would be an asset to the board of directors of young and emerging life science companies. " and "Karin and I have worked together extensively during the development and growth of the Diagnostics business initiative at Horizon. Karin has been instrumental in maximising the product development opportunities during this time, directing/enabling a range of activities from ideation through to manufacture and also adoption of ISO quality systems (9001 & 13485). Her attention to detail is impeccable and in addition to her scientific background, Karin has excellent contractual skills which have really helped maintain momentum during key collaborations. Karin's exceptional scientific breadth and depth has been a critical source of value for many of the projects I have worked with her on and this is reflected in the quality of the teams that she manages."